212 related articles for article (PubMed ID: 30460108)
1. Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity.
Jang J; Oh H; Nam D; Seol W; Seo MK; Park SW; Kim HG; Seo H; Son I; Ho DH
Anim Cells Syst (Seoul); 2018; 22(5):273-280. PubMed ID: 30460108
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells.
Ho DH; Nam D; Seo MK; Park SW; Seol W; Son I
Oxid Med Cell Longev; 2021; 2021():9969842. PubMed ID: 34306319
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.
Tozzi A; Tantucci M; Marchi S; Mazzocchetti P; Morari M; Pinton P; Mancini A; Calabresi P
Cell Death Dis; 2018 Feb; 9(2):204. PubMed ID: 29434188
[TBL] [Abstract][Full Text] [Related]
5. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.
Ho DH; Kim H; Kim J; Sim H; Ahn H; Kim J; Seo H; Chung KC; Park BJ; Son I; Seol W
Mol Brain; 2015 Sep; 8():54. PubMed ID: 26384650
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
Ho DH; Seol W; Son I
Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis.
Quintero-Espinosa DA; Sanchez-Hernandez S; Velez-Pardo C; Martin F; Jimenez-Del-Rio M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445652
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
Ilieva NM; Hoffman EK; Ghalib MA; Greenamyre JT; De Miranda BR
Neurobiol Dis; 2024 Jun; 196():106522. PubMed ID: 38705492
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.
Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
Neurochem Res; 2016 Oct; 41(10):2675-2692. PubMed ID: 27394417
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.
Heo HY; Park JM; Kim CH; Han BS; Kim KS; Seol W
Exp Cell Res; 2010 Feb; 316(4):649-56. PubMed ID: 19769964
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.
Howlett EH; Jensen N; Belmonte F; Zafar F; Hu X; Kluss J; Schüle B; Kaufman BA; Greenamyre JT; Sanders LH
Hum Mol Genet; 2017 Nov; 26(22):4340-4351. PubMed ID: 28973664
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity.
Karuppagounder SS; Xiong Y; Lee Y; Lawless MC; Kim D; Nordquist E; Martin I; Ge P; Brahmachari S; Jhaldiyal A; Kumar M; Andrabi SA; Dawson TM; Dawson VL
J Chem Neuroanat; 2016 Oct; 76(Pt B):90-97. PubMed ID: 26808467
[TBL] [Abstract][Full Text] [Related]
14. G2019S LRRK2 Increases Stress Susceptibility Through Inhibition of DAF-16 Nuclear Translocation in a 14-3-3 Associated-Manner in
Long S; Guo W; Hu S; Su F; Zeng Y; Zeng J; Tan EK; Ross CA; Pei Z
Front Neurosci; 2018; 12():782. PubMed ID: 30464741
[TBL] [Abstract][Full Text] [Related]
15. Ciliogenesis is Not Directly Regulated by LRRK2 Kinase Activity in Neurons.
Kim H; Sim H; Lee JE; Seo MK; Lim J; Bang Y; Nam D; Lee SY; Chung SK; Choi HJ; Park SW; Son I; Kim J; Seol W
Exp Neurobiol; 2021 Jun; 30(3):232-243. PubMed ID: 34230223
[TBL] [Abstract][Full Text] [Related]
16. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL
J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology.
Xiong Y; Neifert S; Karuppagounder SS; Stankowski JN; Lee BD; Grima JC; Chen G; Ko HS; Lee Y; Swing D; Tessarollo L; Dawson TM; Dawson VL
eNeuro; 2017; 4(2):. PubMed ID: 28321439
[TBL] [Abstract][Full Text] [Related]
18. LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation.
Ho DH; Je AR; Lee H; Son I; Kweon HS; Kim HG; Seol W
Exp Neurobiol; 2018 Jun; 27(3):171-180. PubMed ID: 30022868
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening.
Lavalley NJ; Slone SR; Ding H; West AB; Yacoubian TA
Hum Mol Genet; 2016 Jan; 25(1):109-22. PubMed ID: 26546614
[TBL] [Abstract][Full Text] [Related]
20. G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses.
Ho DH; Lee H; Son I; Seol W
Anim Cells Syst (Seoul); 2019 Apr; 23(2):106-111. PubMed ID: 30949397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
